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Background& aim: Sarcopenia, the age-related decrease in muscle mass, strength, and function, is a main
cause of reduced mobility, increased falls, fractures and nursing home admissions. Cross-sectional and
prospective studies indicate that sarcopenia may be influenced in part by reversible factors like nutritional
intake. The aim of this study was to compare functional and nutritional status, body composition, and
quality of life of older adults between age and sex-matched older adults with and without sarcopenia.
Methods: In a multi-centre setting, non-sarcopenic older adults (n ¼ 66, mean ± SD: 71 ± 4 y), i.e. Short
Physical Performance Battery (SPPB): 11e12 and normal skeletal muscle mass index, were recruited to
match 1:1 by age and sex to previously recruited adults with sarcopenia: SPPB 4e9 and low skeletal
muscle mass index. Health-related quality of life, self-reported physical activity levels and dietary intakes
were measured using the EQ-5D scale and index, Physical Activity Scale for the Elderly (PASE), and 3-day
prospective diet records, respectively. Concentrations of 25-OH-vitamin D, a-tocopherol (adjusted for
cholesterol), folate, and vitamin B-12 were assessed in serum samples.
Results: In addition to the defined components of sarcopenia, i.e. muscle mass, strength and function,
reported physical activity levels and health-related quality of life were lower in the sarcopenic adults
(p < 0.001). For similar energy intakes (mean ± SD: sarcopenic, 1710 ± 418; non-sarcopenic, 1745 ± 513,
p ¼ 0.50), the sarcopenic group consumed less protein/kg (6%), vitamin D (38%), vitamin B-12 (22%),
magnesium (6%), phosphorus (5%), and selenium (2%) (all p < 0.05) compared to the non-sarcopenic
controls. The serum concentration of vitamin B-12 was 15% lower in the sarcopenic group (p ¼ 0.015),
and all other nutrient concentrations were similar between groups.
Conclusions: In non-malnourished older adults with and without sarcopenia, we observed that sarco-
penia substantially impacted self-reported quality of life and physical activity levels. Differences in
nutrient concentrations and dietary intakes were identified, which might be related to the differences in
muscle mass, strength and function between the two groups. This study provides information to help
strengthen the characterization of this geriatric syndrome sarcopenia and indicates potential target areas
for nutritional interventions.
© 2015 The Authors. Published by Elsevier Ltd and European Society for Clinical Nutrition and
Metabolism. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Advanced Medical Nutrition,
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Sarcopenia is a syndrome that is defined predominantly by the
simultaneous occurrence of low skeletal muscle mass, strength and
function [1]. The definition of sarcopenia overlaps partially with
physical frailty [2], and the consequences of both syndromes are
increased incidence of falls and fractures, loss of independence, and
increased rates of hospitalization. Poor dietary intake has been
associated with individual components of sarcopenia, possibly due
to dietary pattern changes, reduced response of ageing muscle to
anabolic stimuli from meals (anabolic resistance), or oxidative
stress from ageing and co-morbidities [3].
Higher dietary intake of protein has been consistently associated
with greater muscle mass in older adults [3e5]. Consequently, a
higher recommended protein intake of 1.0e1.2 g/kg body weight
was recently proposed for healthy maintenance of ageing muscles
and up to 1.2e1.5 g/kg body weight/day for older adults with acute
or chronic disease [6,7]. Several serum nutrient deficiencies (or
inadequacies) are associated with measures of sarcopenia through
pathways that are still not well-understood [3]. The risk of
becoming frail increases with the number of micronutrient de-
ficiencies [8]. A low 25-OH-vitamin D level was cross-sectionally
related to appendicular lean mass, leg strength and leg muscle
quality [9], and also to functional outcomes such as increased rates
of falls and nursing home admissions [10,11] among older adults.
Vitamin B12, B6 and folate are nutrients that may have an impact
on sarcopenia, since they help to reduce serum levels of homo-
cysteine, higher levels of which are related to reduced muscle
strength and gait speed [12e14].
Relatively little information is available comparing nutrient
intake and serum nutrient concentrations between sarcopenic and
healthy older adults [1]. Such knowledge can help to eventually
guide health care professionals in identifying the most appropriate
nutritional recommendations and interventions. The goal of this
study was to compare functional and nutritional status, body
composition, and quality of life of older adults between age and
sex-matched older adults with and without sarcopenia.
2. Methods
2.1. Study design and participants
This study is based on a matched case-control observational
cohort of older adults with sarcopenia and their non-sarcopenic
controls.
Older adults with sarcopenia were selected from the PROVIDE
study population. The PROVIDE study was a multi-centre ran-
domized controlled trial investigating the effect of a vitamin D and
leucine-enriched whey protein supplement on muscle mass,
strength and function in older adults with sarcopenia. The PROVIDE
study is registered under the Dutch trial register with the identifier:
NTR2329. A total of 380 volunteers with sarcopenia participated in
this 13-week intervention, which is published elsewhere [15]. The
major eligibility criteria for the sarcopenic participants (i.e. cases)
were: 1) Aged 65 years; 2) a short physical performance battery
(SPPB) score of 4e9; 3) low skeletal muscle mass index (SMI:
skeletal muscle mass/BW 100): 37% (men) and 28% (women)
measured using bioelectric impedance analysis (BIA 101 Akern,
Florence, Italy) [16]; 4) a body mass index (BMI) between 20 and
30 kg/m2; 5) were able and willing to provide written informed
consent. A sub-sample of these sarcopenic participants (n ¼ 66)
whowere screened and recruited between June 2010 andMay 2013
from sites in the United Kingdom was matched with non-
sarcopenic controls. Non-sarcopenic controls were identified
through advertisements, contacts to organisations such as seniorPlease cite this article in press as: Verlaan S, et al., Nutritional status, bod
and non-sarcopenic older adults: A case-control study, Clinical Nutritionclubs, churches, sports centres and associations offering activities
for older people, as well as by word of mouth through other po-
tential volunteers who had expressed interest but did not meet the
study criteria.
Non-sarcopenic older adults (n¼ 66) were recruited tomatch by
age (- 1 year, þ 2 years accepted) and sex with a ratio of 1:1 to the
sarcopenic participants. They were identified from three sites in the
United Kingdom (Manchester, Lancashire and Newcastle) between
September 2013 and June 2014; using the following inclusion
criteria: 1) Aged  65 years; 2) a SPPB score of 11e12; 3) Normal
SMI defined as SMI one standard deviation below the sex-specific
mean for young adults (aged 18e40), using BIA [16] or DXA [17]; 4)
a body mass index (BMI) between 20 and 30 kg/m2; 5) able and
willing to provide written informed consent.
2.2. Outcome measures and data collection
All data from the sarcopenic older adults were collected at the
screening or baseline visit of the intervention trial (i.e. before the
start of the nutritional intervention). Data on background charac-
teristics, nutritional status, anthropometrics and physical perfor-
mancewere collected on a single visit (in a few cases blood samples
were collected during a second visit) from the non-sarcopenic
controls.
2.2.1. Anthropometry
Body composition was assessed using dual energy x-ray ab-
sorptiometry (DXA, different models from Hologic, Bedford, USA;
and Lunar, Fairfield, USA). Appendicular muscle mass (arms and
legs) and fat mass (total) were measured and a central check was
done to ensure uniformity in the analysis.
2.2.2. Muscle strength and function
Handgrip strength was measured using a hydraulic hand
dynamometer (Jamar™, Preston, Jackson, Missouri, USA). Two
consecutive measures of grip strength in each hand were recorded
to the nearest kg with the participant in an upright position and the
arm of the measured hand parallel to the body. Maximum grip
strength was calculated by taking the average of the highest mea-
surement from both hands.
SPPB consists of three components: gait speed (4-m walk at a
usual pace), chair stand test (time taken to rise five consecutive
times from a chair as quickly as possible without arm rests), and
balance (feet side-by-side, semi-tandem and tandem) according to
the method outlined by Guralnik et al. [18]. Each component was
scored from 0 (not possible) to 4 (best performance) and summed
in a total score ranging from 0 to 12.
2.2.3. Reported physical activity levels and health-related quality of
life
Self-reported amount of physical activity was measured using
the European version of the Physical Activity Scale for the Elderly
(PASE). The Barthel index was used to measure the level of inde-
pendence in activities of daily living with possible scores between
0 and 100 (highest scores best). Health-related quality of life was
measured using the EQ-5D, both as an index and as a visual
analogue scale (VAS) between 0 and 100.
2.2.4. Assessment of frailty status
Participants in both groups were categorized into non-frail, pre-
frail, or frail based on adapted Fried [19] criteria. The following
criteria were used: 1) involuntary weight loss; having responded
“yes” to a question on the mini-nutritional assessment short-form
about experiencing involuntary weight loss of 1e3 kg or more
than 3 kg in the past 3 months; 2) exhaustion; having respondedy composition, and quality of life in community-dwelling sarcopenic
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points considered normal) about whether they feel full of energy;
3) physical inactivity; having a PASE questionnaire score of <64 for
men and <52 for women; 4) slowwalking speed [19]; 5) low hand-
grip strength relative to BMI [19]. Participants were considered
non-frail if none of the criteria were met, pre-frail if 1 or 2 of the
criteria were met, and frail if 3e5 of the criteria were met.
2.2.5. Nutritional assessment
The mini nutritional assessment short form (MNA-SF®) was
used to ask questions related to malnutrition. The answers to the
questions resulted in a score from 0 to 14 points. Participants were
then categorised into normal nutritional status (12e14 points), at
risk for malnutrition (8e11 points), or malnourished (0e7 points).
2.2.5.1. Dietary intake. Participants in both the sarcopenic and non-
sarcopenic groups were asked to complete 3-day dietary intake
records over two weekdays and one weekend day. This dietary
assessment took place after the study visit, andwas returned by the
participants within two weeks. Food diaries were quality checked
and entered by trained dieticians, and portion sizes were translated
to gram weight amounts using site-specific dietary data entry
systems, which included: Windiets; CompEat (Pro Version 5.8.0.);
and DietPlan (6.70.67). The gramweights of food intake were then
converted to energy, macronutrient and micronutrient amounts
using the following food composition tables: McCance and Wid-
owson 5th and 6th edition, and the UKN UK Nutrient databank.
2.2.5.2. Serum nutrient concentrations. Serum samples were taken
in a fasted state at the screening visit for the sarcopenic participants
or during the single study visit for the non-sarcopenic controls.
Samples were left at room temperature for 30 min and were then
centrifuged. The alliquoted serum was stored at 20 or 80C.
Analytical testing for serum vitamin D (25-OH-D), vitamin B-12,
and folate were performed at Reinier de Graaf Groep medical lab-
oratory, Delft, the Netherlands using chemiluminescense micro-
particulate immunoassay (Abbott Laboratories, Wiesbaden, Ger-
many) (25-OH-D), and competitive protein binding ligand (CPBL)
(vitamin B-12 and folate). For 25-OH-D, compared to a
chromatography-based reference method, the recovery of endog-
enous 25-OH-vitamin both D3 and D2 species were 105% and 85%,
respectively. To evaluate the effect of season on serum 25-OH-D, we
stratified the participants by season of blood draw: summer
(JuneeNovember) and winter (DecembereMay) [20]. Analytical
testing of serum vitamin-E was performed at Nutricia Research,
Utrecht, using HPLC and spectroflurometry, and total cholesterol
was analysed enzymatically, followed by colometry at Reinier de
Graaf Groep, Medical Laboratory.
Serum concentrations were considered inadequate or deficient
if they were below: vitamin D (25-OH-D), 50 nmol/L [21]; vitamin
B-12, 200 pmol/L [22]; folate, 10 nmol/L [23]; vitamin E:cholesterol
ratio, 2.25 mmol/mmol [24].
2.3. Ethics
The study protocol was reviewed and approved by The Research
Ethics Boards at each of the locations and was registered with the
Dutch trials register with the identifier: NTR2329 [15] (http://www.
trialregister.nl/trialreg).
2.4. Statistical analyses
Data were checked for normal distributions using the Shaprio-
Wilk test and visual inspection of the group histograms. Contin-
uous data that followed a normal distribution was described withPlease cite this article in press as: Verlaan S, et al., Nutritional status, bod
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were performed by paired t-tests. When distributions were not
normal, the data were described with medians and interquartile
ranges and between-group comparisons were done using the
Wilcoxon signed-rank test. Categorical variables were presented as
percentages and either the Wilcoxon signed-rank test (ordinal
data), McNemar (dichotomous data) or the Bhapkar test (nominal
data) was performed to test for significant differences between the
matched pairs. Only complete matched pairs for each outcome
were used in the analyses. P-values <0.05 were considered statis-
tically significant. All statistical analyses were performed in SAS
(Version 9.4).
3. Results
In total, 253 non-sarcopenic older adults were screened ac-
cording to the inclusion criteria, until 66 eventually met the in-
clusion criteria, agreed to participate, and were matched
successfully to adults with sarcopenia based on age and sex (Fig. 1).
All participants were reported to be living independently and both
groups had similar low rates of fall incidents in the past year
(Table 1).
In accordance with the inclusion criteria, gait-speed, balance
score and chair-stand time were all significantly worse in the sar-
copenic sample versus the non-sarcopenic controls. Handgrip
strength was significantly lower in the sarcopenic sample than in
the non-sarcopenic controls. The sarcopenic group had a signifi-
cantly higher mean body weight by 3.5 kg (p ¼ 0.015) and 6 kg
more fat mass (p < 0.001) than the non-sarcopenic controls.
Appendicular muscle mass was 1.4 kg lower in the sarcopenic
sample than the non-sarcopenic controls (p ¼ 0.001) (Table 2).
The sarcopenic participants reported significantly less physical
activity than the non-sarcopenic adults (PASE) and significantly
lower ability to perform daily activities (Barthel index) (Table 1).
Sarcopenic older adults reported having a poorer health-related
quality of life than the non-sarcopenic adults, both on the visual
analogue scale and the 5-domain index (Table 1). The sarcopenic
participants were more likely to be frail (14%) or pre-frail (71%)
compared to the non-sarcopenic participants where nonewere frail
and 30% were pre-frail (p < 0.001).
3.1. Nutritional parameters
The majority of participants in both groups were non-
malnourished according to the MNA (Table 1). There were no sig-
nificant differences in energy intake or intake of carbohydrate or
fat. When expressed as percentages of energy, the sarcopenic
sample had slightly lower percentage energy from carbohydrates,
but the percentages of energy from fat (and all types of fatty acids)
were not significantly different between the sarcopenic sample and
the non-sarcopenic control sample. Protein intake relative to body
weight was significantly lower in the sarcopenic group (6%
different), but no difference was observed when expressed as gram
intake/day or as a percentage of energy. Vitamin B-12 (22%
different), Vitamin D (38% different), phosphorus (5% different),
and selenium (2% different) were all statistically significantly
lower in the sarcopenic sample than the non-sarcopenic controls.
Intakes of all other nutrients did not differ between the groups
(Table 3).
Serum Vitamin B-12 concentrations were significantly lower in
the sarcopenic versus the non-sarcopenic control group of older
adults (mean ± SD 284 ± 107 pmol/L vs. mean ± SD
335 ± 120 pmol/L, p¼ 0.015). Likewise, a larger proportion of adults
with sarcopenia was considered deficient in vitamin B-12
comparedwith the non-sarcopenic controls (26% vs.11%, p¼ 0.033)y composition, and quality of life in community-dwelling sarcopenic
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Fig. 1. Participant recruitment, screening and enrolment.
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the two groups. There were more non-sarcopenic control blood
draws in the winter (DecembereMay) (n ¼ 48) than in the summer
(JuneeNovember) (n ¼ 16), versus a relative balance in the number
of blood draws of the sarcopenic older adults in the summer
(n ¼ 34) and winter (n ¼ 29) seasons. 25-OH-Vitamin D concen-
trations were significantly different (p ¼ 0.017) between non-
sarcopenic and sarcopenic older adults in the summer, but not in
the winter season (Fig. 2).4. Discussion
Compared to age- and sex-matched non-sarcopenic seniors,
older adults with sarcopenia reported significantly lower health-
related quality of life and self-reported physical activity levels.
These older adults with sarcopenia had higher body weights, lower
appendicular muscle mass and higher fat mass than their non-
sarcopenic controls, despite the dietary energy intakes being
roughly equal between the groups. Dietary nutrient intakes ofPlease cite this article in press as: Verlaan S, et al., Nutritional status, bod
and non-sarcopenic older adults: A case-control study, Clinical Nutritionprotein (g/kg/day) vitamin B-12, vitamin D, magnesium, phos-
phorus, and selenium were significantly lower in the sarcopenic
sample. Serum vitamin B-12 was different between the groups,
with a significantly lower concentration among sarcopenic older
adults.4.1. Quality of life and frailty
In agreement with previous studies, we found that adults with
sarcopenia have significantly lower health-related quality of life
compared to non-sarcopenic older adults [25]. We also observed
that the sarcopenic adults had a slightly higher GDS score, although
both groups were well within the “normal” range. Depression, a
GDS score of 10 or greater, however, is associated with lower
appendicular muscle mass and thus sarcopenia [26]. Likewise, the
functional independence measured by the Barthel index was high
in both groups, with significantly more sarcopenic adults with
scores below 100 compared to the non-sarcopenic adults. Lower
scores on the Barthel index are associated with sarcopenia likelyy composition, and quality of life in community-dwelling sarcopenic
(2015), http://dx.doi.org/10.1016/j.clnu.2015.11.013
Table 1
Characteristics and demographics of older adults with and without sarcopenia.
Sarcopenic older adults n ¼ 66 Non-sarcopenic older adults n ¼ 66 p-value
Sex, female, n (%)a 39 (59.1) 39 (59.1)
Age (y), mean (SD)a 71.1 (4.4) 71.0 (4.4)
MNA non-malnourished n (%)b 62 (93.9) 64 (97.0) 0.625
MNA at risk for malnutrition n (%) 4 (6.1) 2 (3.0)
Current smoker, n (%)c 14 (21.2) 3 (4.5) 0.001
Alcohol consumption, yes n (%)b 55 (84.6) 59 (89.4) 0.439
Number of medical visits, n (%)b
1 visit in past month 11 (16.7) 18 (27.7) 0.004
2 visits in past month 2 (3.0) 7 (10.8)
Frailty status, No frailty, n (%)b 10 (15.4) 45 (70.3) <0.001
Pre-frail 46 (70.8) 19 (29.7)
Frail 9 (13.8) 0 (0)
Number of falls, none, n (%)b 60 (90.9) 61 (93.8) 0.590
Geriatric Depression Scale, median (IQR)b 1 (0, 2) 0 (0, 1) <0.001
MMSE, median (IQR)b 29 (28, 30) 29 (28, 30) 0.966
PASE questionnaire, total score, mean (SD)d 148 (73.3) 193 (73.6) <0.001
Health-related QOL (EQ-5D), index, pointsd 0.79 (0.16) 0.94 (0.09) <0.001
Health-related QOL (EQ-5D), VAS, mmd 79.4 (13.3) 89.5 (7.8) <0.001
Barthel index, highest score (score of 100), n (%)b 48 (72.7) 64 (98.5) <0.001
a Participants were matched 1:1 by sex and age (- 1 year, þ2 years allowed).
b Wilcoxon Signed-Rank test.
c Bhapkar test for paired nominal data.
d Paired t-test for matched pairs.
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centage of sarcopenic adults that were non-frail according to these
criteria. This suggests that sarcopenia is a risk factor for frailty, but
sarcopenia can occur without concurrent frailty.
4.2. Body composition
Body composition, lean body mass:fat mass ratio were different,
regardless of height and BMI. This difference in body composition
highlights the fact that sarcopenia may present itself either as a
condition with malnutrition and weight loss, as also evidenced by
the Hertfordshire cohort study [28], or alongside higher adiposity
as shown in this study. High fat mass coinciding with sarcopenia
poses greater risks for continued and hastened declines in mobilityTable 2
Body composition and Muscle Strength and Function.
Sarcopenic old
Body Composition
Weight, kg, mean (SD)a 73.9 (11.1)
Height, m, mean (SD)a 1.67 (0.09)
BMI, kg/mb, mean (SD)a 26.5 (2.2)
Appendicular Muscle Mass, kg, DXA, mean (SD)a 19.0 (4.4)
Men, mean (SD)a 23.2 (3.0)
Women, mean (SD)a 16.0 (2.1)
Appendicular Muscle Mass/heightb, kg/mb, DXA, mean (SD)a 6.8 (1.0)
Men, mean (SD)a 7.6 (0.7)
Women, mean (SD)a 6.2 (0.6)
Fat mass, kg, DXA, mean (SD)a 27.7 (5.6)
Fat mass, %, DXA, mean (SD)a 37.4 (6.0)
Muscle Strength and Function
SPPB score, median (IQR)b 8.0 (7.0, 9.0)
4e6, n (%)b 14 (21.2)
7-9 52 (78.8)
10-12 0 (0)
Handgrip strength, kg, mean (SD)b 23.2 (8.4)
Men, mean (SD)b 29.8 (8.2)
Women, mean (SD)b 18.6 (4.6)
Gait-speed, m/s, mean (SD)a 0.83 (0.20)
Balance score, points, median (IQR)b 4 (3, 4)
Chair-stand time, seconds, median (IQR)b 19.3 (17.4, 23.0
a Paired t-test for matched pairs.
b Wilcoxon Signed-Rank test.
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infiltration of the muscle [29]. The different phenotypes of sarco-
penia may have different requirements for energy, protein and
micronutrient and may thus require specific nutritional in-
terventions and recommendations.4.3. Nutritional status
Therewas a small, but significant difference in the dietary intake
of protein (g/kg bodyweight/day) between the sarcopenic and non-
sarcopenic older adults. Although the mean intake in the sarco-
penic group was within the low range of the most recent recom-
mendations for healthy older adults (1.0e1.2 g/kg bw/day [6,7]),
this intake level may still not be adequate to prevent or treater adults n ¼ 66 Non-sarcopenic older adults n ¼ 66 p-value
70.4 (11.3) 0.015
1.65 (0.09) 0.192
25.6 (2.8) 0.040
20.4 (5.0) <0.001
25.8 (2.6) 0.003
16.6 (1.7) 0.130
7.4 (1.2) <0.001
8.6 (0.7) <0.001
6.5 (0.5) 0.010
21.8 (6.0) <0.001
31.1 (7.4) <0.001
12.0 (11.0, 12.0) <0.001
0 (0)
0 (0)
66 (100)
29.4 (8.7) <0.001
37.5 (7.5) 0.002
24.0 (4.0) <0.001
1.23 (0.19) <0.001
4 (4, 4) <0.001
) 10.0 (9.2, 11.1) <0.001
y composition, and quality of life in community-dwelling sarcopenic
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Table 3
Average daily dietary energy and nutrient intakes by sarcopenic and non-sarcopenic older adults.
Mean (SD)a p-value
Sarcopenic older adults n ¼ 66 Non-sarcopenic older adults n ¼ 66
Energy (kcal) 1710 (418) 1745 (513) 0.496
Macronutrients
Protein (g) 72.5 (19.6) 75.3 (20.7) 0.359
Protein (g/kg BW) 0.99 (0.24) 1.09 (0.29) 0.044
% E from Protein 17.4 (3.8) 17.8 (3.7) 0.685
Carbohydrate (g) 212 (61) 208 (76) 0.906
% E from Carbohydrates 46.9 (6.3) 44.5 (7.3) 0.045
Total Fat (g) 63.3 (19.0) 65.8 (22.1) 0.403
% E from Fat 32.6 (5.7) 33.1 (5.9) 0.649
% E from Saturated fat 12.1 (3.2) 12.0 (3.1) 0.912
% E from Monounsaturated fat 10.8 (2.8) 10.9 (2.6) 0.856
% E from Polyunsaturated fat 5.5 (1.9) 5.5 (1.7) 0.731
Micronutrients
Vitamin B-6 (mg) 2.0 (0.9) 2.0 (0.8) 0.871
Vitamin B-12 (mg), median (IQR)b 3.9 (2.6, 5.9) 5.3 (3.6, 6.9) 0.011
Folate (mg) 246 (107) 261 (101) 0.351
Vitamin C (mg) 92.1 (71.6) 98.6 (59.4) 0.543
Vitamin D (mg) 2.6 (2.1) 4.0 (3.4) 0.007
Vitamin E equivalent (mg) 7.4 (4.0) 8.0 (3.8) 0.493
Calcium (mg) 813 (301) 846 (289) 0.506
Magnesium (mg) 260 (96) 295 (86) 0.015
Phosphorus (mg) 1196 (330) 1325 (338) 0.014
Selenium (mg) 39.1 (17.1) 46.5 (21.2) 0.039
Zinc (mg) 8.2 (3.0) 9.0 (2.6) 0.087
a Paired t-test for matched pairs.
b Wilcoxon Signed-Rank test.
S. Verlaan et al. / Clinical Nutrition xxx (2015) 1e86sarcopenia. Furthermore, there were significantly lower intakes of
some micronutrients by the sarcopenic adults compared to the
non-sarcopenic controls. Compared to the British daily reference
nutrient intakes (RNIs) [30], both groups seemed to have
“adequate” mean micronutrient intakes except vitamin D and se-
lenium. This evident micronutrient “sufficiency” is not uncommon
among the UK's older adults, where the national diet and nutrition
survey (2008e2010) found that adults over 65 years met or
exceeded all micronutrient RNIs except for vitamin D [31]. How-
ever, micronutrient sufficiency in terms of the RNI might not be
sufficient to preserve functional outcomes of sarcopenia. For
example, vitamin B-12 intakes in both groups were above the RNI,
but the sarcopenic group had significantly lower intakes than the
non-sarcopenic controls, which was reflected in the serum con-
centrations of vitamin B-12. There was a significantly higher per-
centage of sarcopenic older adults (26%) below the deficiency cut-
off level of 200 pmol/L [22], versus 11% in the non-sarcopenic
controls.
Both groups had mean daily vitamin D intakes below the RNI of
10ug, which is the same as the newest Institute of Medicine's
estimated average requirement (EAR) [21]. Lower vitamin D levels,Table 4
Descriptive statistics comparing serum biomarkers between adults with and without sa
Mean (SD)
Sarcopenic older
Serum 25-OH-D, nmol/L, mean (SD, CV)a 52.9 (22.3, 42.1)
Deficient (50.0 nmol/L), n (%) 33 (52.4)
Serum vitamin E: cholesterol mmol/mmol, mean (SD, CV)a 6.2 (1.2, 20.1)
Deficient (2.25 mmol/mmol), n (%) 0
Serum vitamin B-12, pmol/L, mean (SD, CV)a 284 (107, 38)
Deficient (200.0 pmol/L), n (%) 17 (26.2)
Serum folate, nmol/L, mean (SD, CV)a 22.1 (11.2, 50.7)
Deficient (10 nmol/L), n (%) 9 (13.8)
Use of nutritional supplements, yes, n (%)b 13 (19.7)
a Paired t-test for matched pairs.
b Wilcoxon Signed-Rank test.
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and non-sarcopenic older adults: A case-control study, Clinical Nutritionhowever, are also associated with components of sarcopenia.
Considering themobility limitations and subsequent lower physical
activity levels (as confirmed by the PASE questionnaire) of the
sarcopenic older adults, sun exposure and, consequently, 25-OH-D
levels were expected to be lower in this group compared to the
non-sarcopenic controls. The sarcopenic group in our study had
significantly lower vitamin D intakes than the non-sarcopenic
group, but we did not observe a difference in serum concentra-
tions between the groups. This may due to a bias in our assessment
given the greater number of non-sarcopenic adults sampled in the
winter months. This seasonality of vitamin D concentrations,
especially in the UK, is common [20,32] and is compounded by the
fact that older adults spend more hours outdoors in the summer
and autumn months [20].
The generally lower micronutrient density of the sarcopenic
group's diets and the nutrient intakes that were significantly lower
(vitamin B-12, vitamin D, magnesium, phosphorus, and selenium)
could signal a lower quality of the diet in the sarcopenic group.
Thus, a group of nutrients rather than individual nutrients could
also contribute to lower muscle mass, strength and function of
sarcopenia. Scott et al. (2010), for example, showed that higherrcopenia.
p-value
adults n ¼ 66 Non-sarcopenic older adults n ¼ 66
55.7 (24.1, 43.2) 0.399
30 (46.9) 0.336
6.5 (1.4, 21.3) 0.127
0 n/a
335 (120, 36) 0.015
7 (10.9) 0.033
19.8 (8.8, 44.6) 0.211
6 (9.4) 0.439
12 (18.2) 0.827
y composition, and quality of life in community-dwelling sarcopenic
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Fig. 2. Total serum 25-OH-vitamin D concentration between group differences, stratified by season of sample collection.
S. Verlaan et al. / Clinical Nutrition xxx (2015) 1e8 7intakes of calcium, magnesium, niacin, phosphorus, potassium,
riboflavin and zinc, had positive increasing trends for increased
appendicular muscle mass [5].
4.4. Limitations
Given the cross-sectional nature of the study, we cannot
comment about causation and the directions in which the relation-
ships we observe exist; i.e. whether sarcopenia causes changes in
nutritional status orwhether nutritional status causes changes in the
development of sarcopenia. However, the data do provide a clinical
snapshot of adults living with sarcopenia, and suggest that there are
potential gaps in the diet. This information could help to build future
nutrition interventions. In addition,we recognize that there is awide
range of clinical presentations of patients with sarcopenia and our
results might not be widely generalizable outside the limits of our
inclusion criteria and age-group.
4.5. Strengths
Having matched non-sarcopenic controls to sarcopenic adults
on two of the strongest unmodifiable risk factors: age and sex
(females have a higher risk of sarcopenia than men) [33], we were
able to carefully examine other characteristics as potentially
contributing to the pathogenesis of sarcopenia. Another strength of
our study is that the outcomes were assessed using the same
methods, after identical training and within a similar time frame.
We used a robust and appropriate dietary assessment method for
community-dwelling older adults, which likely improved the ac-
curacy of our group means [34]. A 3-day food intake record is
considered a strong assessment method [34] versus diet histories,
food frequency questionnaires and even 24-h recalls since they
allow the participants to directly record their food intake. This does
not exclude potential omissions or intrusions on the records, but itPlease cite this article in press as: Verlaan S, et al., Nutritional status, bod
and non-sarcopenic older adults: A case-control study, Clinical Nutritionprevents relying exclusively on memory to accurately recall all
foods and drinks consumed [34], which must be an important
consideration in older populations.
5. Conclusion
By comparing age and sex-matched older adults without
protein-energy malnutrition, we observed that sarcopenia signifi-
cantly impacts self-reported quality of life and physical activity
level. There were differences in nutrient concentrations and dietary
intakes, which might be related to differences in muscle mass,
strength and function between the two groups. Certain groups of
micronutrients and macronutrients and their relationship to sar-
copenic parameters suggest that nutrients work in harmony with
each other, and that isolating a single “problem” nutrient for sar-
copenic interventions may not adequately address the problem.
This study provides information to help strengthen the character-
ization of this geriatric syndrome sarcopenia and indicates poten-
tial target areas for nutritional interventions.
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